Invention Grant
- Patent Title: Heterocyclic compounds as CRTH2 receptor antagonists
- Patent Title (中): 杂环化合物作为CRTH2受体拮抗剂
-
Application No.: US12681356Application Date: 2008-10-09
-
Publication No.: US08772312B2Publication Date: 2014-07-08
- Inventor: Wei W. Yuan
- Applicant: Wei W. Yuan
- Applicant Address: CN Hebei CN Beijing
- Assignee: CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.,Centaurus Biopharma Co., Ltd.
- Current Assignee: CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.,Centaurus Biopharma Co., Ltd.
- Current Assignee Address: CN Hebei CN Beijing
- Agency: The Marbury Law Group, PLLC
- International Application: PCT/US2008/079303 WO 20081009
- International Announcement: WO2009/049021 WO 20090416
- Main IPC: C07D471/06
- IPC: C07D471/06 ; A61K31/437 ; C07D471/14
Abstract:
This application relates to a compound of Formula ! (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an antagonist of receptor CRTH2, as well as a process for its preparation and intermediates therefor.
Public/Granted literature
- US20100222270A1 HETEROCYCLIC COMPOUNDS AS CRTH2 RECEPTOR ANTAGONISTS Public/Granted day:2010-09-02
Information query
